Indefinite Delivery Contract 36C24924D0006

Award Date 10/1/23
Last Date to Order 9/30/28
Ultimate Awardee
Cardinal Health, Inc.
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV award is held by Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., to provide radiopharmaceuticals and related products to the U.S. Department of Veterans Affairs (VA). The single-award Indefinite Delivery Contract (IDC), valued at $88,137.20, covers the supply of LYMPHOSEEK, a specialized radiopharmaceutical agent used for lymph node imaging, to the VA Long Beach Healthcare System from January 1, 2025, through December 31, 2029. Cardinal Health 414 has...
The federal contract IDV award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., is for the provision of radiopharmaceuticals to the Lexington VA Medical Center. The contract was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 (VISN 9) with a ceiling value of $2,221,551.01 and a period of performance through September 30, 2029. The contract includes a $506,365.00 delivery order for radiopharmaceuticals, with a firm fixed-price pricing...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) between the Department of Veterans Affairs (VA) and Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued at $510,185.95, is for the supply of radiopharmaceuticals to support nuclear medicine, oncology, and diagnostic imaging services at VA medical centers nationwide. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to...
The federal contract IDV awarded by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) to Cardinal Health 414, LLC is for the provision of radiopharmaceuticals. Cardinal Health 414, LLC is a subsidiary of Cardinal Health, Inc., a global healthcare services company. The $1,877,644.52 IDV has a period of performance through September 30, 2025 and allows for ongoing deliveries of a wide range of radiopharmaceuticals, including technetium-99m, iodine-123, iodine-131, and...
The federal contract IDV award is for the supply of nuclear medicine radiopharmaceuticals to the Department of Veterans Affairs (VA), particularly to VA medical facilities in the VA Integrated Service Network 2 region. The prime contractor, Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., has been awarded a single-award IDV contract valued up to $714,324.27, with a period of performance through September 3, 2027. Under this IDV, Cardinal Health 414 will provide a range of...
This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA), specifically the VA Loma Linda Healthcare System (VALLHCS), to the prime contractor Cardinal Health 414, LLC. The contract, valued at $378,989.96, is for the supply of the radiopharmaceutical Lymphoseek and F-18 FDG Bulk MEDRAD to support medical imaging procedures at the VA Loma Linda facility. The contract was awarded as a sole source, single award, firm fixed-price IDIQ agreement under the...
This federal contract IDV award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., is for the delivery of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $833,238.27 and a period of performance through September 30, 2027. Cardinal Health 414 is an experienced supplier of critical medical isotopes, radiopharmaceuticals, and specialized pharmaceutical products to federal healthcare agencies, including the VA, Department...
The Department of Veterans Affairs (VA) awarded an indefinite delivery contract (IDC) to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract, valued at $350,000, is for the manufacturing and delivery of radiopharmaceuticals to VA medical centers. This single-award IDC has a base period of performance from November 12, 2024 to November 11, 2025. Under this contract, Cardinal Health 414 will provide a range of radiopharmaceuticals,...
The federal contract IDV award, valued at $1,359,373.23, was granted to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The contract, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16, is for the provision of radiopharmaceutical supplies to support the VA's nuclear medicine, oncology, and diagnostic imaging programs. The task order issued under this IDV, valued at $246,012.64, is for the delivery of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded a single award Indefinite Delivery Contract to Cardinal Health 414, LLC for the supply of radiopharmaceuticals including Lymphoseek and F-18 FDG. The contract has a potential value of $516,393.75 and a period of performance from October 1, 2023 through September 30, 2028 to support nuclear medicine diagnostic services at VA facilities in Memphis, Tennessee. A firm fixed price...
  • 36C24924D0006
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

The federal contract IDV award is held by Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract provides for the delivery of LYMPHOSEEK RADIOPHARMACEUTICAL products to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9.

The contract is a single-award Indefinite Delivery Contract (IDC) with a ceiling value of $25,554.41 and a performance period running through September 30, 2028. Two delivery orders have been issued under this IDC, valued at $26,261.20 and $4,662.70 respectively, for the supply of LYMPHOSEEK RADIOPHARMACEUTICAL to VA medical facilities in Kentucky. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialized pharmaceutical products to federal healthcare agencies like the VA, Department of Defense, and National Institutes of Health. The company holds multiple IDV contracts with the VA, ranging from $1 million to $39.8 million, to support the agency's ongoing need for critical nuclear medicine products used in diagnostic imaging for veterans.

Generated 2/26/25, 9:48 AM